AVR 4.08% $12.49 anteris technologies ltd

Musings of a ‘mug’ RI playing the Stockmarket., page-2

  1. 27,363 Posts.
    lightbulb Created with Sketch. 1776
    With RAP, ResAppDx is an unique technology with currently no competitor. The OSA diagnosis is also unique, there is one competitor that has gotten regulatory approval mid last year but it only works on iPhone smartphone and certain AHI range unlike RAP's which works on both and all AHI ranges, RMD announced only mid last year they where partnering with Google to develop a mobile diagnosis tool.....and there lies the problem with AHZ (which made it worst by commercialising the medical product themself without using other partners and their connection in this field).
    I wish I had fallen in love with CSL.....
 
watchlist Created with Sketch. Add AVR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.